Abstract
Patients with lymph node involvement have less favorable prognosis and higher risk of recurrence. A label-free quantitative proteomic strategy is applied to construct plasma proteomes of ten patients with different lymph node statuses. The present dataset provides a list of candidate biomarkers that can be used for early diagnosis and prognosis of breast cancer with lymph node metastasis. This is reported by Ling Chen, Weibo Zhao, Jing He, Liqi Li, Dong Meng, Dongyan Cai, Jinjin Yu, Daozhen Chen, Yibo Wu and Tao Zhou, article number 1700117.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
